Singleton Mark Leonard bought BVS
March 14, 2025 · Form 4 insider transaction
Singleton Mark Leonard bought 54,000 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 368 days after the transaction.
Direction
Acquired (buy-side)
Shares
54,000
Price
$0.00
Total value
N/A
InsiderSingleton Mark Leonard
Role—
CompanyBioventus Inc. (BVS)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 14, 2025
Filing dateMarch 17, 2026
Shares owned after54,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.; The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.